All In Biotech

Drug Trial Radar · NCT06351917

Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

Last checked: Nov 20, 2026Latest source record: Dec 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Apr 24, 2024

Primary completion

Jun 18, 2024

Study completion Jun 18, 2024

Sponsor

Lead sponsor
RDC Clinical Pty LtdIndustry
Sponsor type
Industry
First posted
Apr 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomised, double-blind, placebo controlled, 2 arm parallel clinical trial to evaluate the effect of topical PlexoZome® Levagen® spray on relief of post exercise knee joint pain in healthy adults compared to placebo over 4 weeks duration.

Conditions

  • Knee Joint Pain

Interventions

  • PlexoZome® Levagen® topical spray solutionDrug

    PlexoZome® Levagen® topical spray solution 10mg/g providing 1.8mg active per pump

  • Placebo topical spray solutionDrug

    Placebo topical spray solution topical spray solution 0mg/g providing 0mg active per pump

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Joint painTime frame: Up to 5 knee pain treatment events for up to 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • RDC Clinical Pty Ltd

    Brisbane, Queensland, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.